Cargando…

Excessive levels of nitric oxide in rat model of Parkinson’s disease induced by rotenone

Systemic rotenone models of Parkinson’s disease (PD) are highly reproducible and may provide evidence on the pathogenesis of PD. In the present study, male Sprague-Dawley rats (1-year-old) were subcutaneously administered with rotenone (1.5 mg/kg/day) for six days and observed for the following thre...

Descripción completa

Detalles Bibliográficos
Autores principales:	XIONG, ZHONG-KUI, LANG, JUAN, XU, GANG, LI, HAI-YU, ZHANG, YUN, WANG, LEI, SU, YAO, SUN, AI-JING
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280943/ https://www.ncbi.nlm.nih.gov/pubmed/25574233 http://dx.doi.org/10.3892/etm.2014.2099

Ejemplares similares

Chronic administration of rotenone induces Parkinsonian symptoms and increases levels of nitric oxide in rat brain
por: Bashkatova, Valentina, et al.
Publicado: (2008)

Inhibitory Effects of Thermolysis Transformation Products of Rotenone on Nitric Oxide Production
por: Jeong, Gyeong Han, et al.
Publicado: (2023)

Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats
por: Zaitone, Sawsan A., et al.
Publicado: (2012)

Rotenone, Paraquat, and Parkinson’s Disease
por: Tanner, Caroline M., et al.
Publicado: (2011)

The role of autophagy in Parkinson's disease: rotenone-based modeling
por: Xiong, Nian, et al.
Publicado: (2013)

Treadmill exercise alleviates depressive symptoms in rotenone-induced Parkinson disease rats
por: Shin, Mal-Soon, et al.
Publicado: (2017)

Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson's disease model rats★
por: Li, Chun, et al.
Publicado: (2012)

Evidence of Oropharyngeal Dysfunction in Feeding in the Rat Rotenone Model of Parkinson's Disease
por: Gould, François D. H., et al.
Publicado: (2018)

Effect of moxibustion on mTOR-mediated autophagy in rotenone-induced Parkinson's disease model rats
por: Wang, Shu-ju, et al.
Publicado: (2018)

Neuroprotective effects of linagliptin in a rotenone-induced rat model of Parkinson's disease
por: Abhangi, Kinjal V, et al.
Publicado: (2022)

Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
por: Magdy, Alshimaa, et al.
Publicado: (2022)

Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2011)

Stereotaxical Infusion of Rotenone: A Reliable Rodent Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2009)

Anti-inflammatory and Anti-oxidant Activity of Hidrox(®) in Rotenone-Induced Parkinson’s Disease in Mice
por: Siracusa, Rosalba, et al.
Publicado: (2020)

Hibiscetin attenuates oxidative, nitrative stress and neuroinflammation via suppression of TNF-α signaling in rotenone induced parkinsonism in rats
por: Alzarea, Sami I., et al.
Publicado: (2022)

Therapeutic and Neuroprotective Effects of Bushen Jianpi Decoction on a Rotenone-Induced Rat Model of Parkinson's Disease
por: Liang, Wei, et al.
Publicado: (2022)

Acteoside Binds to Caspase-3 and Exerts Neuroprotection in the Rotenone Rat Model of Parkinson's Disease
por: Yuan, Jiawen, et al.
Publicado: (2016)

Fucoidan Protects Dopaminergic Neurons by Enhancing the Mitochondrial Function in a Rotenone-induced Rat Model of Parkinson’s Disease
por: Zhang, Li, et al.
Publicado: (2018)

Protection by the NDI1 Gene against Neurodegeneration in a Rotenone Rat Model of Parkinson's Disease
por: Marella, Mathieu, et al.
Publicado: (2008)

Treadmill exercise alleviates nigrostriatal dopaminergic loss of neurons and fibers in rotenone-induced Parkinson rats
por: Shin, Mal-Soon, et al.
Publicado: (2017)

The rat rotenone model reproduces the abnormal pattern of central catecholamine metabolism found in Parkinson's disease
por: Landau, Regev, et al.
Publicado: (2022)

Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease
por: Zaman, Vandana, et al.
Publicado: (2022)

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
por: Ojha, Shreesh, et al.
Publicado: (2015)

Baicalein Attenuates Brain Iron Accumulation through Protecting Aconitase 1 from Oxidative Stress in Rotenone-Induced Parkinson’s Disease in Rats
por: Liu, Run-Zhe, et al.
Publicado: (2022)

Minocycline Protects against Rotenone-Induced Neurotoxicity Correlating with Upregulation of Nurr1 in a Parkinson's Disease Rat Model
por: Sun, Congcong, et al.
Publicado: (2019)

Chronic sleep restriction in the rotenone Parkinson’s disease model in rats reveals peripheral early-phase biomarkers
por: Fagotti, Juliane, et al.
Publicado: (2019)

Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson’s disease in rats
por: Ahmed, Sanaa, et al.
Publicado: (2022)

Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice
por: Pan-Montojo, Francisco, et al.
Publicado: (2010)

Non-Reproducibility of Oral Rotenone as a Model for Parkinson’s Disease in Mice
por: Niederberger, Ellen, et al.
Publicado: (2022)

Differences in brain pathological changes between rotenone and 6-hydroxydopamine Parkinson’s disease models
por: Liu, Lan-Xiang, et al.
Publicado: (2018)

Zinc and linoleic acid pre-treatment attenuates biochemical and histological changes in the midbrain of rats with rotenone-induced Parkinsonism
por: Mbiydzenyuy, Ngala Elvis, et al.
Publicado: (2018)

Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism
por: Chiu, Ching-Chi, et al.
Publicado: (2014)

Neuroprotective Effects of a Standardized Flavonoid Extract from Safflower against a Rotenone-Induced Rat Model of Parkinson’s Disease
por: Ablat, Nuramatjan, et al.
Publicado: (2016)

Olfactory impairment is related to REM sleep deprivation in rotenone model of Parkinson's disease
por: Aurich, Mariana F., et al.
Publicado: (2017)

Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson’s Disease Models
por: Zhang, Yu, et al.
Publicado: (2019)

Neuroprotective effects of Danshensu on rotenone-induced Parkinson’s disease models in vitro and in vivo
por: Wang, Tian, et al.
Publicado: (2020)

Neuroprotective effects of curcumin on the cerebellum in a rotenone‐induced Parkinson’s Disease Model
por: Fikry, Heba, et al.
Publicado: (2022)

Melatonin Mitigates Rotenone-Induced Oxidative Stress and Mitochondrial Dysfunction in the Drosophila melanogaster Model of Parkinson’s Disease-like Symptoms
por: Rasheed, Md. Zeeshan, et al.
Publicado: (2023)

Barbigerone Potentially Alleviates Rotenone-Activated Parkinson’s Disease in a Rodent Model by Reducing Oxidative Stress and Neuroinflammatory Cytokines
por: Alharthy, Khalid M., et al.
Publicado: (2023)

Ceruloplasmin Protects Against Rotenone-Induced Oxidative Stress and Neurotoxicity
por: Hineno, Akiyo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kfafepe09g7219macg2ma0206q